Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration
about
Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersSerum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis.The Role of Metabolomics in Brain Metabolism ResearchDisrupted sphingolipid metabolism following acute clozapine and olanzapine administration.
P2860
Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Neurochemical Metabolomics Rev ...... nic Haloperidol Administration
@ast
Neurochemical Metabolomics Rev ...... nic Haloperidol Administration
@en
type
label
Neurochemical Metabolomics Rev ...... nic Haloperidol Administration
@ast
Neurochemical Metabolomics Rev ...... nic Haloperidol Administration
@en
prefLabel
Neurochemical Metabolomics Rev ...... nic Haloperidol Administration
@ast
Neurochemical Metabolomics Rev ...... nic Haloperidol Administration
@en
P2093
P2860
P1476
Neurochemical Metabolomics Rev ...... nic Haloperidol Administration
@en
P2093
Angela M Batman
Edwin J van den Oord
Patrick M Beardsley
Robert E Vann
Sarah A Vunck
P2860
P2888
P304
P356
10.1007/S11481-015-9605-1
P577
2015-04-08T00:00:00Z